United States Vivo CRO Market Insight
Published: 29 July 2026 | Report Format: Electronic (PDF) | Author: Aditi and Govind
The United States In Vivo CRO Market is projected to grow at a CAGR of around 8.6% over the forecast period, driven by increasing outsourcing of preclinical research and growing focus on translational research and regulatory compliance
United States Vivo CRO Market Forecasts to 2035
- The United States In Vivo CRO Market size was estimated at approximately USD 2.45 Billion in 2025.
- The market is expected to grow at a CAGR of around 8.6% from 2025 to 2035.
- The United States In Vivo CRO Market is projected to reach approximately USD 5.58 Billion by 2035.
Notable Insights for the United States Vivo CRO Market
- Segmentation based on service type indicates that Toxicology Studies, Pharmacokinetics & Pharmacodynamics (PK/PD), Efficacy Studies, Safety Assessment, and Bioanalysis Services account for nearly 89% of market revenue in 2025, supported by increasing outsourcing of preclinical testing by pharmaceutical and biotechnology companies.
- Segmentation based on application shows that Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, and Metabolic Disorders collectively hold nearly 91% market share in 2025, driven by expanding therapeutic research pipelines and biologics development.
- Growing adoption of humanized animal models, AI-assisted preclinical data analysis, digital pathology, advanced imaging technologies, automated laboratory workflows, and GLP-compliant research platforms contributes to more than 65% of new technology deployments in 2025.
Download the eBook (ToC)
- Rising investments in biopharmaceutical R&D, precision medicine, laboratory automation, translational research infrastructure, and advanced animal research facilities account for nearly 67% of new capital expenditure across the United States In Vivo CRO industry
Research Methodologies Used to Analyze United States Vivo CRO Market
The United States In Vivo CRO Market is analyzed using primary and secondary research methodologies to ensure accurate market estimates and forecasts. Primary research includes interviews with pharmaceutical companies, biotechnology firms, CRO executives, preclinical researchers, academic institutions, laboratory managers, regulatory professionals, and industry experts. Secondary research covers company annual reports, FDA publications, NIH resources, scientific journals, biotechnology association reports, CRO industry databases, government healthcare statistics, and market intelligence databases. Data triangulation, competitive benchmarking, pricing analysis, market share evaluation, supply chain assessment, regulatory analysis, and statistical forecasting models are applied to validate findings and provide reliable market forecasts through 2035.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Vivo CRO Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Vivo CRO Market
- Charles River Laboratories
- Labcorp Drug Development
- IQVIA Laboratories
- Inotiv, Inc.
- WuXi AppTec
- Crown Bioscience
- Altasciences
- Pharmaron
- Taconic Biosciences
- Evotec SE.
Recent Developments:
- In May 2025, Charles River Laboratories expanded its preclinical in vivo research capabilities with enhanced toxicology and translational medicine services to support biologics and cell & gene therapy development.
- In February 2025, Inotiv, Inc. announced investments in advanced in vivo research infrastructure and digital laboratory technologies to improve study efficiency, data quality, and regulatory compliance.
Market Segmentation
United States Vivo CRO Market, By Service Type
- Toxicology Studies
- Pharmacokinetics & Pharmacodynamics (PK/PD)
- Efficacy Studies
- Safety Assessment
- Bioanalysis Services
United States Vivo CRO Market, By End-Use Industry
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutes
- Medical Device Companies
- Government Research Organizations
United States Vivo CRO Market, By Application
- Oncology
- Neurology
- Cardiovascular Diseases
- Infectious Diseases
- Immunology
Expert Views:
The United States In Vivo CRO Market is expected to witness robust growth through 2035, supported by increasing outsourcing of preclinical research, rising biologics and precision medicine development, expanding pharmaceutical R&D investments, and growing regulatory requirements for comprehensive safety evaluation. Continued advancements in AI-enabled preclinical analytics, digital pathology, advanced animal models, laboratory automation, high-resolution imaging, and translational research technologies are expected to improve study accuracy, operational efficiency, and research productivity. Furthermore, increasing investments in drug discovery, biotechnology innovation, laboratory infrastructure, precision therapeutics, and regulatory-compliant research services are anticipated to create significant growth opportunities for CRO providers, pharmaceutical manufacturers, biotechnology companies, academic institutions, and research organizations across the United States.
Author: Aditi and Govind By Decisions Advisors and Consulting